Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06450977
Other study ID # REMIND
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date June 7, 2024
Est. completion date December 31, 2026

Study information

Verified date June 2024
Source University of Illinois at Urbana-Champaign
Contact Naiman Khan, PhD
Phone 2173001667
Email nakhan2@illinois.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to learn if increasing adherence to a Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet pattern improves thinking ability and memory compared to a healthy control diet in persons with Multiple Sclerosis (MS). The main question it aims to answer is: Does the MIND diet improve cognitive performance relative to a control diet in persons with MS? Participants will: Consume one meal that follows the MIND diet or a control meal every day for 3 months, complete online surveys and cognitive testing before and after, and keep a record of the food they eat during the study.


Description:

The purpose of this study is to understand how a healthy diet is related to thinking ability and memory in people with MS. This study is fully remote consisting of meals being delivered to participant homes using Daily Harvest meal delivery service. Participants will be asked to consume a microwaveable study meal or prepackaged smoothie every day for 12 weeks. The study meals and smoothies will follow either a dietary pattern thought to improve brain health (MIND), or a control diet, and will include foods commonly found in grocery stores. Participants will not know which diet they are assigned to (active or control). Participants will also be asked to follow simple dietary guidance on a healthy diet in addition to the meals provided. Participants will complete a series of online forms or surveys. Additionally, participants will complete an online cognitive battery (CANTAB) at the beginning and end of the study.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date December 31, 2026
Est. primary completion date January 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: 1. Individuals aged 18-64 years old 2. Self-reported diagnosis of Multiple sclerosis (MS) 3. 20/20 or corrected vision 4. No other neurodegenerative disease diagnosis 5. Stable disease-modifying therapy (DMT) within 6 months 6. Not Pregnant or lactating 7. No food allergies or intolerances 8. Able to consume study meals 9. Not enrolled in another dietary, exercise, or medication study during the study 10. Access to a computer/laptop with internet Exclusion Criteria: 1. Individuals younger than 18 or older than 64 years old 2. No self-reported diagnosis of Multiple sclerosis (MS) 3. Not 20/20 or uncorrected vision 4. Other neurodegenerative disease diagnosis 5. Disease modifying therapy (DMT) less than 6 months 6. Pregnant or lactating 7. Food allergies or intolerances 8. Not able to consume study meals 9. Enrolled in another dietary, exercise, or medication study during the study 10. No access to a computer/laptop with internet

Study Design


Related Conditions & MeSH terms


Intervention

Other:
MIND Diet
Daily meals designed to increase adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) dietary pattern.
Control Diet
Daily meals designed to increase fruit, vegetable, and whole grain intake consistent with a healthy American diet.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Illinois at Urbana-Champaign

Outcome

Type Measure Description Time frame Safety issue
Primary Information Processing Rapid Visual Information Processing Task from CANTAB online battery 12 weeks (Baseline vs. Follow Up)
Primary Visual Processing Match to Sample Visual Search from CANTAB online battery 12 weeks (Baseline vs. Follow Up)
Primary Processing Speed Digit Span from CANTAB online battery 12 weeks (Baseline vs. Follow Up)
Primary Learning Paired Associates Learning Task from CANTAB online battery 12 weeks (Baseline vs. Follow Up)
Primary Memory Spatial Working Memory from CANTAB online battery 12 weeks (Baseline vs. Follow Up)
Secondary MIND Scores MIND dietary pattern scores calculated from diet records/surveys 12 weeks (Baseline vs. Follow Up)
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis